NEW YORK, Nov. 6, 2017 /PRNewswire/ -- At least 30% of the haematologists we surveyed don't prescribe the 7 leading haemophilia B treatments we asked them about. But most are willing to consider them, so there's room for brands to grow. To seize that opportunity, you need to understand the market barriers that are preventing doctors from prescribing your brand, and address the ones that are costing you market share. Read the full report: https://www.reportlinker.com/p05175252Market Access Impact: Haemophilia B (US) shows you how 7 barriers affect your market share, revealing which competitors you take share from, and which ones gets your lost share.Based on a survey of 100 US-based haematologists, the report covers 6 major therapies from Bioverativ, CSL Behring, Pfizer, and Shire. Top Takeaways
Read the full report: https://www.reportlinker.com/p05175252 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
- Barriers affect a quarter of prescriptions: But three barriers affect far more prescriptions than the rest.
- A problem for most doctors: 70% or more of doctors experience at least one barrier with each brand.
- One brand is suffering disproportionately: More doctors experience nearly every barrier more with this brand than with any other.
- Downward pressure: Net share losses tend to be bigger than net gains, largely because brands are losing additional share to "other" brands not included in the survey.
- There's room to grow: None of the surveyed brands is prescribed by more than about 70% of doctors, but most doctors are willing to consider brands they don't currently prescribe.
- Eliminating barriers would close market share gaps: Tight races for first, third, and fifth place would emerge, intensifying competition.
Advertisement
Read the full report: https://www.reportlinker.com/p05175252 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/market-access-impact-haemophilia-b-us-300550382.html
SOURCE Reportlinker